-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $230

Benzinga·10/26/2026 14:04:17
语音播报
Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $167 to $230.